- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
According to our latest study, the global Antibody Therapeutics and Blood Antibody Therapeutics market size was valued at USD 196950 million in 2022 and is forecast to a readjusted size of USD 371150 million by 2029 with a CAGR of 9.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report is a detailed and comprehensive analysis for global Antibody Therapeutics and Blood Antibody Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Therapeutics and Blood Antibody Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Therapeutics and Blood Antibody Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibody Therapeutics and Blood Antibody Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
IgG1
IgG4
Others
Market segment by Application
Autoimmune
Tumor
Others
Market segment by players, this report covers
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Therapeutics and Blood Antibody Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Therapeutics and Blood Antibody Therapeutics, with revenue, gross margin and global market share of Antibody Therapeutics and Blood Antibody Therapeutics from 2018 to 2023.
Chapter 3, the Antibody Therapeutics and Blood Antibody Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Therapeutics and Blood Antibody Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Therapeutics and Blood Antibody Therapeutics.
Chapter 13, to describe Antibody Therapeutics and Blood Antibody Therapeutics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Antibody Therapeutics and Blood Antibody Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Therapeutics and Blood Antibody Therapeutics by Type
1.3.1 Overview: Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 IgG1
1.3.4 IgG4
1.3.5 Others
1.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market by Application
1.4.1 Overview: Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Autoimmune
1.4.3 Tumor
1.4.4 Others
1.5 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size & Forecast
1.6 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast by Region
1.6.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.1.4 Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.2.4 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbvie Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.3.4 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.4.4 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.5.4 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.6.4 Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments and Future Plans
2.7 Alexion Pharmaceuticals
2.7.1 Alexion Pharmaceuticals Details
2.7.2 Alexion Pharmaceuticals Major Business
2.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.7.4 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Alexion Pharmaceuticals Recent Developments and Future Plans
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.8.4 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.9.4 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amgen Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.10.4 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biogen Recent Developments and Future Plans
2.11 UCB
2.11.1 UCB Details
2.11.2 UCB Major Business
2.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.11.4 UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 UCB Recent Developments and Future Plans
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.12.4 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly and Company Recent Developments and Future Plans
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
2.13.4 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antibody Therapeutics and Blood Antibody Therapeutics by Company Revenue
3.2.2 Top 3 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share in 2022
3.2.3 Top 6 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share in 2022
3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Market: Region Footprint
3.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Type Footprint
3.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
6.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
7.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region
8.3.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
9.3 South America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
9.3.1 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
10.3.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
11.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
11.3 Antibody Therapeutics and Blood Antibody Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Chain
12.2 Antibody Therapeutics and Blood Antibody Therapeutics Upstream Analysis
12.3 Antibody Therapeutics and Blood Antibody Therapeutics Midstream Analysis
12.4 Antibody Therapeutics and Blood Antibody Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 8. Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Abbvie Company Information, Head Office, and Major Competitors
Table 11. Abbvie Major Business
Table 12. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 13. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbvie Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 18. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Johnson & Johnson Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 23. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. Novartis Company Information, Head Office, and Major Competitors
Table 26. Novartis Major Business
Table 27. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 28. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Novartis Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 33. Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck Recent Developments and Future Plans
Table 35. Alexion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Alexion Pharmaceuticals Major Business
Table 37. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 38. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Alexion Pharmaceuticals Recent Developments and Future Plans
Table 40. Takeda Company Information, Head Office, and Major Competitors
Table 41. Takeda Major Business
Table 42. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 43. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Takeda Recent Developments and Future Plans
Table 45. Amgen Company Information, Head Office, and Major Competitors
Table 46. Amgen Major Business
Table 47. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 48. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Amgen Recent Developments and Future Plans
Table 50. Biogen Company Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 53. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Recent Developments and Future Plans
Table 55. UCB Company Information, Head Office, and Major Competitors
Table 56. UCB Major Business
Table 57. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 58. UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. UCB Recent Developments and Future Plans
Table 60. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 61. Eli Lilly and Company Major Business
Table 62. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 63. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Eli Lilly and Company Recent Developments and Future Plans
Table 65. AstraZeneca Company Information, Head Office, and Major Competitors
Table 66. AstraZeneca Major Business
Table 67. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
Table 68. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. AstraZeneca Recent Developments and Future Plans
Table 70. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 71. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players (2018-2023)
Table 72. Breakdown of Antibody Therapeutics and Blood Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Antibody Therapeutics and Blood Antibody Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Antibody Therapeutics and Blood Antibody Therapeutics Players
Table 75. Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Type Footprint
Table 76. Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Application Footprint
Table 77. Antibody Therapeutics and Blood Antibody Therapeutics New Market Entrants and Barriers to Market Entry
Table 78. Antibody Therapeutics and Blood Antibody Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Share by Type (2018-2023)
Table 81. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 82. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023)
Table 83. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 84. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Antibody Therapeutics and Blood Antibody Therapeutics Raw Material
Table 115. Key Suppliers of Antibody Therapeutics and Blood Antibody Therapeutics Raw Materials
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. IgG1
Figure 5. IgG4
Figure 6. Others
Figure 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application in 2022
Figure 9. Autoimmune Picture
Figure 10. Tumor Picture
Figure 11. Others Picture
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Region in 2022
Figure 17. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Players in 2022
Figure 23. Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Antibody Therapeutics and Blood Antibody Therapeutics Market Share in 2022
Figure 25. Global Top 6 Players Antibody Therapeutics and Blood Antibody Therapeutics Market Share in 2022
Figure 26. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Share by Type (2018-2023)
Figure 27. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share Forecast by Type (2024-2029)
Figure 28. Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Share by Application (2018-2023)
Figure 29. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share Forecast by Application (2024-2029)
Figure 30. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 40. France Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 47. China Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 50. India Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 64. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Figure 65. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Figure 66. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Antibody Therapeutics and Blood Antibody Therapeutics in 2022
Figure 69. Manufacturing Process Analysis of Antibody Therapeutics and Blood Antibody Therapeutics
Figure 70. Antibody Therapeutics and Blood Antibody Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
